Live feed
Filing
SC 13G/A
SC 13G/A0001104659-17-002193·OncoMed Pharmaceuticals Inc
Schedule 13G ownership disclosure
ONCOMED PHARMACEUTICALS INC
Security class unavailable · CUSIP: 68234X102
Event date: 2017-01-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,119,905
- Percent of class
- 3.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-002193
- Form type
- SC 13G/A
- Filer
- OncoMed Pharmaceuticals Inc
- CIK
- CIK 1302573
- Filed
- Jan 13, 2017
- Reporting period
- Jan 10, 2017
- Description
- Schedule 13G beneficial ownership